These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2100277)

  • 1. Production of interleukin-1 alpha and interleukin-2 by mononuclear cells from children with growth delay in relation to the degree of growth hormone deficiency: effects of substitutive treatment.
    Casanova S; Repellin AM; Schimpff RM
    Horm Res; 1990; 34(5-6):209-14. PubMed ID: 2100277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of interleukin-1-alpha and interleukin-2 by mononuclear cells in healthy adults in relation to different experimental conditions and to the presence of growth hormone.
    Schimpff RM; Repellin AM
    Horm Res; 1990; 33(5):171-6. PubMed ID: 2272609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum cytokine levels in GH-deficient children during substitutive GH therapy.
    Pagani S; Meazza C; Travaglino P; De Benedetti F; Tinelli C; Bozzola M
    Eur J Endocrinol; 2005 Feb; 152(2):207-10. PubMed ID: 15745927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
    Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
    J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V; Di Biase S; Lettiero T; Labella D; Simeone R; Salerno M
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The wide variation in urinary excretion of human growth hormone in normal growing and growth hormone-deficient children limits its clinical usefulness.
    Léger J; Reverchon C; Porquet D; Noël M; Czernichow P
    Horm Res; 1995; 44(2):57-63. PubMed ID: 7590633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum propeptide and intact molecular osteocalcin in normal children and children with growth hormone (GH) deficiency: a potential marker of bone growth and response to GH therapy.
    Kanzaki S; Hosoda K; Moriwake T; Tanaka H; Kubo T; Inoue M; Higuchi J; Yamaji T; Seino Y
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1104-9. PubMed ID: 1400878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone (GH)-deficient patients: relationship with GH therapy.
    Spagnoli A; Gargosky SE; Spadoni GL; MacGillivray M; Oh Y; Boscherini B; Rosenfeld RG
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3668-76. PubMed ID: 8530618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cell-mediated immunity in growth hormone-deficient children: effect of therapy with human growth hormone.
    Abbassi V; Bellanti JA
    Pediatr Res; 1985 Mar; 19(3):299-301. PubMed ID: 3982890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune function in growth hormone-deficient children treated with biosynthetic growth hormone.
    Spadoni GL; Rossi P; Ragno W; Galli E; Cianfarani S; Galasso C; Boscherini B
    Acta Paediatr Scand; 1991 Jan; 80(1):75-9. PubMed ID: 2028794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy.
    Serri O; St-Jacques P; Sartippour M; Renier G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):58-63. PubMed ID: 9920062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
    Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bone Gla protein: a potential marker of growth hormone (GH) deficiency and the response to GH therapy.
    Johansen JS; Jensen SB; Riis BJ; Rasmussen L; Zachmann M; Christiansen C
    J Clin Endocrinol Metab; 1990 Jul; 71(1):122-6. PubMed ID: 2370291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC; Malozowski S; Caruso-Nicoletti M; Ross JL; Pescovitz OH; Rose S; Loriaux DL; Cassorla F; Merriam GR
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of growth hormone administration on neurotensin release in children with growth delay.
    Schimpff RM; Bozzola M; Lhiaubet AM; Spadaro B; Tettoni K; Rostène W
    Horm Res; 1994; 42(3):95-9. PubMed ID: 7995619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency.
    Low LC; Wang C; Cheung PT; Ho P; Lam KS; Young RT; Yeung CY; Ling N
    J Clin Endocrinol Metab; 1988 Mar; 66(3):611-7. PubMed ID: 3127420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatomedin production and response to mitogen by lymphocytes in children with growth hormone deficiency.
    Rao JK; Gebhardt BM; Blethen SL
    Growth; 1986; 50(4):456-60. PubMed ID: 3596324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.